Changing shapes of glycogen-autophagy nexus in neurons: Perspective from a rare epilepsy

Frontiers in Neurology

Volumn 6, Issue FEB, 2015, Pages

  Singh, Pankaj Kumar ^a   Singh, Sweta ^a  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

Autophagy; Glycogen; Lafora disease; Neurodegeneration; Polyglucosan

Indexed keywords

CARBOHYDRATE DERIVATIVE; CELL PROTEIN; GLYCOGEN; POLYGLUCOSAN; PROTEIN ATG8; UNCLASSIFIED DRUG;

ARTICLE; AUTOPHAGY; BRAIN NERVE CELL; GLYCOGEN METABOLISM; HUMAN; MYOCLONUS EPILEPSY; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN CARBOHYDRATE INTERACTION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

EID: 84926322618     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2015.00014     Document Type: Article

References (46)

1. Ross CA, Poirier MA. Protein aggregation and neurodegenerative disease. Nat Med (2004) 10(Suppl):S10-7. doi:10.1038/nm1066
2. Hara T, Nakamura K, Matsui M, Yamamoto A, Nakahara Y, Suzuki-Migishima R, et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature (2006) 441:885-9. doi:10.1038/nature04724
3. Rabinowitz JD, White E. Autophagy and metabolism. Science (2010) 330:1344-8. doi:10.1126/science.1193497
4. Saez I, Duran J, Sinadinos C, Beltran A, Yanes O, Tevy MF, et al. Neurons have an active glycogen metabolism that contributes to tolerance to hypoxia. J Cereb Blood Flow Metab (2014) 34:945-55. doi:10.1038/jcbfm.2014.33
5. Sidman RL, Taksir T, Fidler J, Zhao M, Dodge JC, Passini MA. Temporal neuropathologic and behavioral phenotype of 6neo/6neo Pompe disease mice. J Neuropathol Exp Neurol (2008) 67:803-18. doi:10.1097/NEN.0b013e3181815994
6. Ganesh S, Puri R, Singh S, Mittal S, Dubey D. Recent advances in the molecular basis of Lafora's progressive myoclonus epilepsy. J Hum Genet (2006) 51:1-8. doi:10.1007/s10038-005-0321-1
7. Inoue M, Yagishita S, Itoh Y, Amano N, Matsushita M. Coexistence of paired helical filaments and polyglucosan bodies in the same neuron in an autopsy case of Alzheimer's disease. Acta Neuropathol (1996) 92:511-4. doi:10.1007/s004010050553
8. Dodge JC, Treleaven CM, Fidler JA, Tamsett TJ, Bao C, Searles M, et al. Metabolic signatures of amyotrophic lateral sclerosis reveal insights into disease pathogenesis. Proc Natl Acad Sci U S A (2013) 110:10812-7. doi:10.1073/pnas.1308421110
9. Cavanagh JB. Corpora-amylacea and the family of polyglucosan diseases. Brain Res Rev (1999) 29:265-95. doi:10.1016/S0165-0173(99)00003-X
10. Bestetti G, Rossi GL. Hypothalamic lesions in rats with long-term streptozotocin-induced diabetes mellitus. A semiquantitative light- and electron-microscopic study. Acta Neuropathol (1980) 52:119-27. doi:10.1007/BF00688009
11. Ibrahim MZ. The response of the brain to hypoxia and ischaemia. J Neurol Sci (1972) 17:271-9. doi:10.1016/0022-510X(72)90032-9
12. Duran J, Tevy MF, Garcia-Rocha M, Calbó J, Milán M, Guinovart JJ. Deleterious effects of neuronal accumulation of glycogen in flies and mice. EMBO Mol Med (2012) 4:719-29. doi:10.1002/emmm.201200241
13. Sinadinos C, Valles-Ortega J, Boulan L, Solsona E, Tevy MF, Marquez M, et al. Neuronal glycogen synthesis contributes to physiological aging. Aging Cell (2014) 13:935-45. doi:10.1111/acel.12254
14. Cuervo AM. Autophagy and aging: keeping that old broom working. Trends Genet (2008) 24:604-12. doi:10.1016/j.tig.2008.10.002
15. Yokoi S, Austin J, Witmer F, Sakai M. Studies in myoclonus epilepsy (Lafora body form). I. Isolation and preliminary characterization of Lafora bodies in two cases. Arch Neurol (1968) 19:15-33. doi:10.1001/archneur.1968.00480010033002
16. Ganesh S, Delgado-Escueta AV, Sakamotom T, Avila MR, Machado-Salas J, Hoshii Y, et al. Targeted disruption of the Epm2a gene causes formation of Lafora inclusion bodies, neurodegeneration, ataxia, myoclonus epilepsy and impaired behavioral response in mice. Hum Mol Genet (2002) 11:1251-62. doi:10.1093/hmg/11.11.1251
17. Turnbull J, Wang P, Girard JM, Ruggieri A, Wang TJ, Draginov AG, et al. Glycogen hyperphosphorylation underlies Lafora body formation. Ann Neurol (2010) 68:925-33. doi:10.1002/ana.22156
18. Vilchez D, Ros S, Cifuentes D, Pujadas L, Vallès J, García-Fojeda B, et al. Mechanism suppressing glycogen synthesis in neurons and its demise in progressive myoclonus epilepsy. Nat Neurosci (2007) 10:1407-13. doi:10.1038/nn1998
19. Tagliabracci VS, Girard JM, Segvich D, Meyer C, Turnbull J, Zhao X, et al. Abnormal metabolism of glycogen phosphate as a cause for Lafora disease. J Biol Chem (2008) 283:33816-25. doi:10.1074/jbc.M807428200
20. DePaoli-Roach AA, Tagliabracci VS, Segvich DM, Meyer CM, Irimia JM, Roach PJ. Genetic depletion of the malin E3 ubiquitin ligase in mice leads to Lafora bodies and the accumulation of insoluble laforin. J Biol Chem (2010) 285:25372-81. doi:10.1074/jbc.M110.148668
21. Gayarre J, Duran-Trío L, Criado Garcia O, Aguado C, Juana-López L, Crespo I, et al. The phosphatase activity of laforin is dispensable to rescue Epm2a-/- mice from Lafora disease. Brain (2014) 137:806-18. doi:10.1093/brain/awt353
22. Turnbull J, DePaoli-Roach AA, Zhao X, Cortez MA, Pencea N, Tiberia E, et al. PTG depletion removes Lafora bodies and rescues the fatal epilepsy of Lafora disease. PLoS Genet (2011) 7:e1002037. doi:10.1371/journal.pgen.1002037
23. Pederson BA, Turnbull J, Epp JR, Weaver SA, Zhao X, Pencea N, et al. Inhibiting glycogen synthesis prevents Lafora disease in a mouse model. Ann Neurol (2013) 74:297-300. doi:10.1002/ana.23899
24. Turnbull J, Epp JR, Goldsmith D, Zhao X, Pencea N, Wang P, et al. PTG protein depletion rescues malin-deficient Lafora disease in mouse. Ann Neurol (2014) 75:442-6. doi:10.1002/ana.24104
25. Aguado C, Sarkar S, Korolchuk VI, Criado O, Vernia S, Boya P, et al. Laforin, the most common protein mutated in Lafora disease, regulates autophagy. Hum Mol Genet (2010) 19:2867-76. doi:10.1093/hmg/ddq190
26. Criado O, Aguado C, Gayarre J, Duran-Trio L, Garcia-Cabrero AM, Vernia S, et al. Lafora bodies and neurological defects in malin-deficient mice correlate with impaired autophagy. Hum Mol Genet (2012) 21:1521-33. doi:10.1093/hmg/ddr590
27. Puri R, Suzuki T, Yamakawa K, Ganesh S. Dysfunctions in endosomal-lysosomal and autophagy pathways underlie neuropathology in a mouse model for Lafora disease. Hum Mol Genet (2012) 21:175-84. doi:10.1093/hmg/ddr452
28. Kakhlon O, Glickstein H, Feinstein N, Liu Y, Baba O, Terashima T, et al. Polyglucosan neurotoxicity caused by glycogen branching enzyme deficiency can be reversed by inhibition of glycogen synthase. J Neurochem (2013) 127:101-13. doi:10.1111/jnc.12277
29. Duran J, Gruart A, García-Rocha M, Delgado-García JM, Guinovart JJ. Glycogen accumulation underlies neurodegeneration and autophagy impairment in Lafora disease. Hum Mol Genet (2014) 23:3147-56. doi:10.1093/hmg/ddu024
30. Chan EM, Ackerley CA, Lohi H, Ianzano L, Cortez MA, Shannon P, et al. Laforin preferentially binds the neurotoxic starch-like polyglucosans, which form in its absence in progressive myoclonus epilepsy. Hum Mol Genet (2004) 13:1117-29. doi:10.1093/hmg/ddh130
31. Yue Z, Friedman L, Komatsu M, Tanaka K. The cellular pathways of neuronal autophagy and their implication in neurodegenerative diseases. Biochim Biophys Acta (2009) 1793:1496-507. doi:10.1016/j.bbamcr.2009.01.016
32. Wang Y, Yu B, Zhao J, Guo J, Li Y, Han S, et al. Autophagy contributes to leaf starch degradation. Plant Cell (2013) 25:1383-99. doi:10.1105/tpc.112.108993
33. Birgisdottir ÅB, Lamark T, Johansen T. The LIR motif - crucial for selective autophagy. J Cell Sci (2013) 126:3237-47. doi:10.1242/jcs.126128
34. Silver DM, Kötting O, Moorhead GB. Phosphoglucan phosphatase function sheds light on starch degradation. Trends Plant Sci (2014) 19:471-8. doi:10.1016/j.tplants.2014.01.008
35. Zirin J, Nieuwenhuis J, Perrimon N. Role of autophagy in glycogen breakdown and its relevance to chloroquine myopathy. PLoS Biol (2013) 11:e1001708. doi:10.1371/journal.pbio.1001708
36. Behrends C, Sowa ME, Gygi SP, Harper JW. Network organization of the human autophagy system. Nature (2010) 466:68-76. doi:10.1038/nature09204
37. Jiang S, Wells CD, Roach PJ. Starch-binding domain-containing protein 1 (Stbd1) and glycogen metabolism: identification of the Atg8 family interacting motif (AIM) in Stbd1 required for interaction with GABARAPL1. Biochem Biophys Res Commun (2011) 413:420-5. doi:10.1016/j.bbrc.2011.08.106
38. Erdi B, Nagy P, Zvara A, Varga A, Pircs K, Ménesi D, et al. Loss of the starvation-induced gene Rack1 leads to glycogen deficiency and impaired autophagic responses in Drosophila. Autophagy (2012) 8:1124-35. doi:10.4161/auto.20069
39. Singh PK, Singh S, Ganesh S. The laforin-malin complex negatively regulates glycogen synthesis by modulating cellular glucose uptake via glucose transporters. Mol Cell Biol (2012) 32:652-63. doi:10.1128/MCB.06353-11
40. Cid E, Cifuentes D, Baqué S, Ferrer JC, Guinovart JJ. Determinants of the nucleocytoplasmic shuttling of muscle glycogen synthase. FEBS J (2005) 272:3197-213. doi:10.1111/j.1742-4658.2005.04738.x
41. Worby CA, Gentry MS, Dixon JE. Laforin, a dual specificity phosphatase that dephosphorylates complex carbohydrates. J Biol Chem (2006) 281:30412-8. doi:10.1074/jbc.M606117200
42. Zhu Y, Zhang M, Kelly AR, Cheng A. The carbohydrate-binding domain of overexpressed STBD1 is important for its stability and protein-protein interactions. Biosci Rep (2014) 1:34. doi:10.1042/BSR20140053
43. Roach PJ, Depaoli-Roach AA, Hurley TD, Tagliabracci VS. Glycogen and its metabolism: some new developments and old themes. Biochem J (2012) 441:763-87. doi:10.1042/BJ20111416
44. Stapleton D, Nelson C, Parsawar K, Flores-Opazo M, McClain D, Parker G. The 3T3-L1 adipocyte glycogen proteome. Proteome Sci (2013) 11:11. doi:10.1186/1477-5956-11-11
45. Zeng L, Wang Y, Baba O, Zheng P, Liu Y, Liu Y. Laforin is required for the functional activation of malin in endoplasmic reticulum stress resistance in neuronal cells. FEBS J (2012) 279:2467-78. doi:10.1111/j.1742-4658.2012.08627.x
46. Pederson BA, Schroeder JM, Parker GE, Smith MW, DePaoli-Roach AA, Roach PJ. Glucose metabolism in mice lacking muscle glycogen synthase. Diabetes (2005) 54:3466-73. doi:10.2337/diabetes.54.12.3466